CARDIOME PHARMA CORP - COM NO PAR (CRME)

CUSIP: 14159U301

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM NO PAR
Total 13F shares
5,813,782
Share change
+214,282
Total reported value
$46,022,000
Put/Call ratio
640%
Price per share
$7.91
Number of holders
27
Value change
+$1,781,294
Number of buys
17
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 14159U301?
CUSIP 14159U301 identifies CRME - CARDIOME PHARMA CORP - COM NO PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDIOME PHARMA CORP - COM NO PAR (CRME) as of Q1 2014

As of 31 Mar 2014, CARDIOME PHARMA CORP - COM NO PAR (CRME) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,813,782 shares. The largest 10 holders included FMR LLC, ADAGE CAPITAL PARTNERS GP LLC, Fortress Investment Group LLC, Alistair Capital Management, L.L.C., VERTEX ONE ASSET MANAGEMENT INC., WESTFIELD CAPITAL MANAGEMENT CO LP, RENAISSANCE TECHNOLOGIES LLC, Broadfin Capital, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and TURNER INVESTMENTS, L.P.. This page lists 27 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.